Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors

NCT04088604 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: LY01610 ( Irinotecan hydrochloride liposome injection )
DRUG: LY01610 ( Irinotecan hydrochloride liposome injection ) with 5-Fu（Fluorouracil Injection）
DRUG: Irinotecan Hydrochloride Injection（CAMPTO®）

Sponsor

Luye Pharma Group Ltd.